Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124502604> ?p ?o ?g. }
- W2124502604 endingPage "1109" @default.
- W2124502604 startingPage "1102" @default.
- W2124502604 abstract "Prediction of radiographic progression (RP) in early rheumatoid arthritis (eRA) would be very useful for optimal choice among available therapies. We evaluated a multi-biomarker disease activity (MBDA) score, based on 12 serum biomarkers as a baseline predictor for 1-year RP in eRA.Baseline disease activity score based on erythrocyte sedimentation rate (DAS28-ESR), disease activity score based on C-reactive protein (DAS28-CRP), CRP, MBDA scores and DAS28-ESR at 3 months were analysed for 235 patients with eRA from the Swedish Farmacotherapy (SWEFOT) clinical trial. RP was defined as an increase in the Van der Heijde-modified Sharp score by more than five points over 1 year. Associations between baseline disease activity measures, the MBDA score, and 1-year RP were evaluated using univariate and multivariate logistic regression, adjusted for potential confounders.Among 235 patients with eRA, 5 had low and 29 moderate MBDA scores at baseline. None of the former and only one of the latter group (3.4%) had RP during 1 year, while the proportion of patients with RP among those with high MBDA score was 20.9% (p=0.021). Among patients with low/moderate CRP, moderate DAS28-CRP or moderate DAS28-ESR at baseline, progression occurred in 14%, 15%, 14% and 15%, respectively. MBDA score was an independent predictor of RP as a continuous (OR=1.05, 95% CI 1.02 to 1.08) and dichotomised variable (high versus low/moderate, OR=3.86, 95% CI 1.04 to 14.26).In patients with eRA, the MBDA score at baseline was a strong independent predictor of 1-year RP. These results suggest that when choosing initial treatment in eRA the MBDA test may be clinically useful to identify a subgroup of patients at low risk of RP.WHO database at the Karolinska Institute: CT20080004; and clinicaltrials.gov: NCT00764725." @default.
- W2124502604 created "2016-06-24" @default.
- W2124502604 creator A5008691315 @default.
- W2124502604 creator A5012009272 @default.
- W2124502604 creator A5015705695 @default.
- W2124502604 creator A5024484324 @default.
- W2124502604 creator A5026988401 @default.
- W2124502604 creator A5031662324 @default.
- W2124502604 creator A5040915422 @default.
- W2124502604 creator A5073215460 @default.
- W2124502604 creator A5078388888 @default.
- W2124502604 creator A5079197692 @default.
- W2124502604 date "2014-05-08" @default.
- W2124502604 modified "2023-10-01" @default.
- W2124502604 title "Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial" @default.
- W2124502604 cites W1524682237 @default.
- W2124502604 cites W1964095605 @default.
- W2124502604 cites W1965222184 @default.
- W2124502604 cites W1980230927 @default.
- W2124502604 cites W1980455666 @default.
- W2124502604 cites W1996437423 @default.
- W2124502604 cites W2000905503 @default.
- W2124502604 cites W2010544154 @default.
- W2124502604 cites W2024085618 @default.
- W2124502604 cites W2033132851 @default.
- W2124502604 cites W2035741945 @default.
- W2124502604 cites W2037874703 @default.
- W2124502604 cites W2063236332 @default.
- W2124502604 cites W2065952449 @default.
- W2124502604 cites W2066357843 @default.
- W2124502604 cites W2077102864 @default.
- W2124502604 cites W2087075812 @default.
- W2124502604 cites W2093409653 @default.
- W2124502604 cites W2096898523 @default.
- W2124502604 cites W2098279921 @default.
- W2124502604 cites W2100548849 @default.
- W2124502604 cites W2107560119 @default.
- W2124502604 cites W2110177517 @default.
- W2124502604 cites W2110604741 @default.
- W2124502604 cites W2110826367 @default.
- W2124502604 cites W2116314748 @default.
- W2124502604 cites W2117738981 @default.
- W2124502604 cites W2121095925 @default.
- W2124502604 cites W2124428679 @default.
- W2124502604 cites W2124783802 @default.
- W2124502604 cites W2128322769 @default.
- W2124502604 cites W2132031538 @default.
- W2124502604 cites W2136007246 @default.
- W2124502604 cites W2136993556 @default.
- W2124502604 cites W2141629638 @default.
- W2124502604 cites W2143065147 @default.
- W2124502604 cites W2148078801 @default.
- W2124502604 cites W2151855271 @default.
- W2124502604 cites W2166453502 @default.
- W2124502604 cites W2169772272 @default.
- W2124502604 doi "https://doi.org/10.1136/annrheumdis-2013-204986" @default.
- W2124502604 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4431327" @default.
- W2124502604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24812287" @default.
- W2124502604 hasPublicationYear "2014" @default.
- W2124502604 type Work @default.
- W2124502604 sameAs 2124502604 @default.
- W2124502604 citedByCount "83" @default.
- W2124502604 countsByYear W21245026042014 @default.
- W2124502604 countsByYear W21245026042015 @default.
- W2124502604 countsByYear W21245026042016 @default.
- W2124502604 countsByYear W21245026042017 @default.
- W2124502604 countsByYear W21245026042018 @default.
- W2124502604 countsByYear W21245026042019 @default.
- W2124502604 countsByYear W21245026042020 @default.
- W2124502604 countsByYear W21245026042021 @default.
- W2124502604 countsByYear W21245026042022 @default.
- W2124502604 countsByYear W21245026042023 @default.
- W2124502604 crossrefType "journal-article" @default.
- W2124502604 hasAuthorship W2124502604A5008691315 @default.
- W2124502604 hasAuthorship W2124502604A5012009272 @default.
- W2124502604 hasAuthorship W2124502604A5015705695 @default.
- W2124502604 hasAuthorship W2124502604A5024484324 @default.
- W2124502604 hasAuthorship W2124502604A5026988401 @default.
- W2124502604 hasAuthorship W2124502604A5031662324 @default.
- W2124502604 hasAuthorship W2124502604A5040915422 @default.
- W2124502604 hasAuthorship W2124502604A5073215460 @default.
- W2124502604 hasAuthorship W2124502604A5078388888 @default.
- W2124502604 hasAuthorship W2124502604A5079197692 @default.
- W2124502604 hasBestOaLocation W21245026041 @default.
- W2124502604 hasConcept C126322002 @default.
- W2124502604 hasConcept C151956035 @default.
- W2124502604 hasConcept C185592680 @default.
- W2124502604 hasConcept C2777575956 @default.
- W2124502604 hasConcept C2778143017 @default.
- W2124502604 hasConcept C2781197716 @default.
- W2124502604 hasConcept C55493867 @default.
- W2124502604 hasConcept C71924100 @default.
- W2124502604 hasConcept C77350462 @default.
- W2124502604 hasConceptScore W2124502604C126322002 @default.
- W2124502604 hasConceptScore W2124502604C151956035 @default.
- W2124502604 hasConceptScore W2124502604C185592680 @default.
- W2124502604 hasConceptScore W2124502604C2777575956 @default.
- W2124502604 hasConceptScore W2124502604C2778143017 @default.